ストックスクリーナーアプリを入手
98.37
3.94%
-4.03
Revvity Inc (RVTY) 最新ニュース
Dilution adjustment of Revvity, Inc. – XETR:PKN - TradingView
(RVTY) Volatility Zones as Tactical Triggers - Stock Traders Daily
Revvity, Inc. Cash Flow – XETR:PKN - TradingView
Revvity, Inc. Balance Sheet – XETR:PKN - TradingView
Stifel cuts Revvity stock price target on softer valuation - Investing.com
Revvity gains on diagnostics strength, faces China headwinds - MSN
Revvity Inc. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
Why is Revvity (RVTY) up 2% since last earnings report? - MSN
Why Is Revvity (RVTY) Up 2% Since Last Earnings Report? - Yahoo Finance
What to expect from Revvity's next quarterly earnings report - MSN
RVTY Assumed by Wolfe Research -- Rating Set to Peer Perform - GuruFocus
Revvity Inc (RVTY) Stock Down 3.9% -- Now Undervalued? GF Score: 74/100 - GuruFocus
Wolfe Research initiates Revvity stock coverage with Peerperform - Investing.com UK
Wolfe Research Initiates Revvity(RVTY.US) With Hold Rating - Moomoo
Wolfe Research initiates Revvity stock coverage with Peerperform By Investing.com - Investing.com Nigeria
Revvity Inc. stock underperforms Monday when compared to competitors - MarketWatch
Why Is S&P 500 Attention on Revvity After Earnings Miss? - Kalkine Media
Research Tools & Consumables Stocks Q1 In Review: Revvity (NYSE:RVTY) Vs Peers - Yahoo Finance
Revvity, Inc. (RVTY) Stock Analysis: A Healthcare Innovator With 8.7% Potential Upside - DirectorsTalk Interviews
RVTY unveils Signals BioDesign for faster molecular cloning & R&D data - MSN
Revvity Inc. stock (US76155R1086): NYSE price holds near 100 USD as technical levels draw focus - AD HOC NEWS
Revvity Inc. stock (US76155R1086): insider activity and recent trading in focus - AD HOC NEWS
Revvity (RVTY) Q1 earnings and revenues top estimates - MSN
Revvity Inc. stock outperforms competitors on strong trading day - MarketWatch
A Look at Revvity Inc (RVTY) After 4.6% Gain -- GF Value $120.39 vs Price $101.22 - GuruFocus
Revvity stock (US76155R1086): New share repurchase plan sets tone after recent earnings - AD HOC NEWS
Price-Driven Insight from (RVTY) for Rule-Based Strategy - Stock Traders Daily
RVTY Stock Price and Chart — NYSE:RVTY - TradingView
Revvity stock (US76155R1086): life-science player after recent earnings in focus - AD HOC NEWS
Revvity, Inc. (RVTY) Stock Analysis: A Blend of Healthcare Innovation and Notable Growth Potential - DirectorsTalk Interviews
Revvity, Inc. Trade Ideas — XETR:PKN - TradingView
Revvity stock: Analyst estimates & ratings - MSN
Revvity stock (US76155R1086): cancer test launch and steady demand keep diagnostics group in focus - AD HOC NEWS
Revvity declares $0.07 dividend - MSN
Revvity Stock: Analyst Estimates & Ratings - Barchart.com
Revvity stock (US76155R1086): diagnostics specialist in focus after latest earnings and life-science - AD HOC NEWS
Revvity Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Revvity Inc. stock (US76155R1086): investors weigh latest earnings and diagnostics focus - AD HOC NEWS
There May Be Some Bright Spots In Revvity's (NYSE:RVTY) Earnings - 富途牛牛
Revvity's (NYSE:RVTY) Conservative Accounting Might Explain Soft Earnings - Yahoo Finance
Revvity stock (US76155R1086): Q1 earnings beat and guidance set the tone - AD HOC NEWS
Revvity launches Signals BioDesign to advance biologic research workflows - SelectScience
Revvity (RVTY) Is Down 5.0% After Raising 2026 Outlook And Securing FDA Assay Clearance - Sahm
Revvity stock (US76155R1086): FDA assay clearance, outlook to 2026 and fresh collaboration momentum - AD HOC NEWS
Can Revvity Expand Diagnostics Across the S&P 500 Index? - Kalkine Media
Revvity, Inc. (RVTY): Investor Outlook Reveals 20.94% Potential Upside In Healthcare Innovation - DirectorsTalk Interviews
Revvity stock (US76155R1086): steady diagnostics player after latest quarterly update - AD HOC NEWS
RVTY expands endocrine diagnostics with FDA-cleared testosterone assay - MSN
2.13%
2.22%
大文字化:
|
ボリューム (24 時間):